Market Indices
Latest News
 |
| ||
| ||
|
Price Targets
from Canaccord Genuity issued a price target of $13.00 for ATRA on 2026-05-08 08:49:17.The adjusted price target was set to $13.00.At the time of the announcement, ATRA...
May 8, 2026 ATRA 92.82%
from Northland Securities issued a price target of $6.40 for TYGO on 2026-05-07 12:46:59.The adjusted price target was set to $6.40.At the time of the announcement, TYGO...
May 7, 2026 TYGO -2.68%
from Northland Securities issued a price target of $30.00 for MEC on 2026-05-07 12:45:36.The adjusted price target was set to $30.00.At the time of the announcement, MEC...
May 7, 2026 MEC 11.31%
Colin Sebastian from Robert W. Baird issued a price target of $26.00 for LIFE on 2026-05-07 11:37:30.The adjusted price target was set to $26.00.At the time of the announcement,...
May 7, 2026 LIFE 32.31%
from Barclays issued a price target of $27.00 for LIFE on 2026-05-07 09:44:49.The adjusted price target was set to $27.00.At the time of the announcement, LIFE was...
May 7, 2026 LIFE 32.31%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ATRA Atara Biotherapeutics, In | 9.93
92.82% | ||||||||||||||||||
| LIFE Ethos Technologies Inc. | 30.59
32.31% | ||||||||||||||||||
| LCUT Lifetime Brands, Inc. | 7.19
29.08% | ||||||||||||||||||
| ORGNW Origin Materials Inc Warr | 0.00
25.00% | ||||||||||||||||||
| SGHT Sight Sciences, Inc. | 5.29
23.02% | ||||||||||||||||||
| APYX Apyx Medical Corporation | 3.56
21.92% | ||||||||||||||||||
| GDHG Golden Heaven Group Holdi | 1.88
21.29% | ||||||||||||||||||
| LICN Lichen International Limi | 5.79
16.27% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -5.28%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -2.75%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -1.47%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.78%